Toll-like receptor 9 agonists and combination therapies: strategies to modulate the tumour immune microenvironment for systemic anti-tumour immunity.

Dongye, Zhangchi; Li, Jian; Wu, Yuzhang

Dongye, Zhangchi; Li, Jian; Wu, Yuzhang.

Dongye Z; Department of Immunology, Medical College of Qingdao University, 266071, Qingdao, Shandong, PR China.
Li J; Institute of Immunology, PLA, Third Military Medical University (Army Medical University), Chongqing, China.
Wu Y; Institute of Immunology, PLA, Third Military Medical University (Army Medical University), Chongqing, China. seraph-2004@163.com.

Br J Cancer ; 127(9): 1584-1594, 2022 11.

Article en En | MEDLINE | ID: mdl-35902641

Asunto(s)

Neoplasias; Vacunas; Animales; Humanos; Receptor Toll-Like 9/agonistas; Receptor Toll-Like 9/metabolismo; Microambiente Tumoral; Islas de CpG; Oligodesoxirribonucleótidos/uso terapéutico; Adyuvantes Inmunológicos/uso terapéutico; Adyuvantes Inmunológicos/farmacología; Inmunoterapia; Neoplasias/tratamiento farmacológico; Vacunas/uso terapéutico

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / Neoplasias Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / Neoplasias Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article